Answers are grounded in this paper and cite their sources.
Discusses the potential future role of atrial flow regulators for treating pulmonary arterial hypertension.
Despite advances in medical therapy for pulmonary arterial hypertension (PAH), morbidity and mortality due to right heart failure remain high with 5-year survival estimates of 60% [1,2]. Lung tr...
No takes yet. Share an insight, caveat, or question.
Aregullin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: